Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
₹20 L
EMD Value
₹40,000
Closing Date
23 Oct 2026, 11:00 am6d left
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
pmo
PCMO AAO2 NURSING SUPEROVER, MO
MEDICINE
2026_MEDIC_604040_1
1767
Open Tender
Miscellaneous Goods
Item Wise
sardarshahar
Please refer Tender documents.
2 documents required · 2 mandatory
₹1,000
Secretary, RMRS PMO SDH SARDARSHAHAR
₹40,000
Yes
15 Oct 2026
15 Oct 2026
23 Oct 2026
15 Oct 2026
23 Oct 2026
15 Oct 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Medicine Items : | |||||
| 1.01 | Bupivacaine Hydochloride in Dextrose Injection USP Each ml contains Bupivacaine Hydrochloride 5.0 mg Dextrose 80.0 mg | 1 | Nos | - | - |
| 1.02 | Bupivacaine Inj IP 0.5% | 1 | Nos | - | - |
| 1.03 | Halothane BP | 1 | Nos | - | - |
| 1.04 | Isoflurane USP | 1 | Nos | - | - |
| 1.05 | Ketamine Inj IP 50 mg/ml | 1 | Nos | - | - |
| 1.06 | Lignocaine Ointment 5 o/o | 1 | Nos | - | - |
| 1.07 | Lignocaine and Adrenaline Inj IP Each ml. Contains Lignocaine Hydrochloride IP 20 mg Adrenaline IP 0.01 mg | 1 | Nos | - | - |
| 1.08 | Lignocaine Gel IP 2% | 1 | Nos | - | - |
| 1.09 | Lignocaine Inj IP 2 o/o | 1 | Nos | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.78 MB
BOQ_1071371.xls
BOQ • 0.81 MB
nivida.pdf
Tender Documents • 15.85 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .